Digit
18 known investors
Digit Bio operates a platform for functional measurements of cell and gene therapies, providing partners with data on therapeutic mechanism and biodistribution. It works with drug developers to screen and optimize next-generation precision medicines.
Investors · 18
Fifty YearsSan Francisco · $250K – $2M
A91 PartnersreportedMumbai
Goldman SachsreportedNew York
HSBCreportedLondon
Morgan StanleyreportedPurchase
Steadview CapitalreportedSan Francisco
Also in the syndicate · 12
Abu Dhabi Investment AuthorityAxisBay PondEdelweissFairfax GroupFidelityICICIMirae Asset ManagementPeak XVSBITataTVS Capital
Funding
SEC filings, press & company announcements$3M disclosed across 1 of 3 rounds · 2024–2026
- $3MraisedMar 2026 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Digit do?
- Digit Bio operates a platform for functional measurements of cell and gene therapies, providing partners with data on therapeutic mechanism and biodistribution. It works with drug developers to screen and optimize next-generation precision medicines.
- Who are Digit's investors?
- Digit's investors include Fifty Years, A91 Partners, Goldman Sachs, HSBC, Morgan Stanley, Steadview Capital.
- How much funding has Digit raised?
- Digit has disclosed $3M raised across 1 of its 3 known rounds.